The University of Barcelona (UB) becomes a shareholder of Reveal Genomics, a spin-off of the Hospital Clínic Barcelona and the Vall d'Hebron Institute of Oncology (VHIO), which develops precision diagnostic tests in oncology based on different genomic data.
Initially, the company focused on improving the diagnosis of breast cancer.
Reveal Genomics was founded in 2020 and is led by Aleix Prat, head of the Medical Oncology Service at Hospital Clínic, together with Ana Vivancos from the VHIO, Charles M. Perou and Joel S. Parker, from the University of North Carolina-Chapel Hill (USA) and Patricia Villagrasa, CEO of the biotech.
This year they joined CataloniaBio & HealthTech.
Photo: Aleix Prat, Patricia Villagrassa and Ana Vivancos - © Reveal Genomics.
Comments